Differentiation Agents

Differentiation Agent is a type of antineoplastic drug that induces malignant cells to mature into more specialized, functionally normal cells by modulating gene expression and cellular development pathways, thereby inhibiting proliferation and promoting terminal differentiation instead of causing direct cytotoxicity.

188

Publications

7.8K

Citations

839

Authors

240

Institutions

Publications per year

2017–2026

14

Variants

Differentiation-inducing Agents

Authors

839

  1. YH
    Yoshio Honma

    Saitama Cancer Center, Japan

    7 publications · 166 citations

    7

    h-index

  2. TK
    Takashi Kasukabe

    Saitama Cancer Center, Japan

    4 publications · 65 citations

    4

    h-index

  3. GP
    George P. Studzinski

    Rutgers, The State University of New Jersey, United States

    3 publications · 90 citations

    3

    h-index

  4. MK
    Masanori Kuroyanagi

    University of Shizuoka, Japan

    3 publications · 128 citations

    3

    h-index

  5. YK
    Yuzuru Kubohara

    Gunma University, Japan

    3 publications · 104 citations

    3

    h-index

1–5 of 839

Venues

  1. PubMed

    Repository · 55 publications · 2.4K citations

    27

    h-index

  2. Chemical and Pharmaceutical Bulletin

    4 publications · 170 citations

    4

    h-index

  3. Leukemia Research

    4 publications · 95 citations

    4

    h-index

  4. PLoS ONE

    4 publications · 140 citations

    4

    h-index

  5. International Journal of Cancer

    4 publications · 559 citations

    4

    h-index

1–5